Galectin-3 expression in cardiac remodeling after myocardial infarction

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages

  Sanchez Mas, J ^a,d   Lax, A ^a,d   Asensio Lopez, M C ^a,d   Fernandez Del Palacio, M J ^b   Caballero, L ^a,d   Garrido, I P ^a,d   Pastor, F ^a,d   Januzzi, J L ^c   Pascual Figal, D A ^a,d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cardiac remodeling; Fibrosis; Galectin 3; Heart failure; Myocardial infarction

Indexed keywords

CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; GALECTIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENZYME INHIBITION; ENZYME KINETICS; FRACTIONAL FLOW RESERVE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART SIZE; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CARDIAC REMODELING; FIBROSIS; GALECTIN-3; HEART FAILURE; MYOCARDIAL INFARCTION;

ANIMALS; GALECTIN 3; GENE EXPRESSION REGULATION; MALE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 84894072317     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.129     Document Type: Article

References (8)

1. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988 [PubMed: 10869273]
2. Y. Sun Myocardial repair/remodelling following infarction: roles of local factors Cardiovasc Res 81 2009 482 490
3. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R. van Kimmenade, and J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
4. R.R. van Kimmenade, J.L. Januzzi Jr., and P.T. Ellinor et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224
5. J.E. Ho, C. Liu, and A. Lyass et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community J Am Coll Cardiol 60 2012 1249 1256
6. D.J. Lok, S.I. Lok, and P.W. Bruggink-Andre de la Porte et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure Clin Res Cardiol 102 2012 103 110
7. L. Yu, W.P. Ruifrok, and M. Meissner et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis Circ Heart Fail 6 2013 107 117
8. Y.H. Liu, M. D'Ambrosio, and T.D. Liao et al. N-acetyl-seryl-aspartyl- lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin Am J Physiol Heart Circ Physiol 296 2009 H404 H412